Literature DB >> 15477590

The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.

Kathleen H Rubins1, Lisa E Hensley, Peter B Jahrling, Adeline R Whitney, Thomas W Geisbert, John W Huggins, Art Owen, James W Leduc, Patrick O Brown, David A Relman.   

Abstract

Smallpox has played an unparalleled role in human history and remains a significant potential threat to public health. Despite the historical significance of this disease, we know little about the underlying pathophysiology or the virulence mechanisms of the causative agent, variola virus. To improve our understanding of variola pathogenesis and variola-host interactions, we examined the molecular and cellular features of hemorrhagic smallpox in cynomolgus macaques. We used cDNA microarrays to analyze host gene expression patterns in sequential blood samples from each of 22 infected animals. Variola infection elicited striking and temporally coordinated patterns of gene expression in peripheral blood. Of particular interest were features that appear to represent an IFN response, cell proliferation, immunoglobulin gene expression, viral dose-dependent gene expression patterns, and viral modulation of the host immune response. The virtual absence of a tumor necrosis factor alpha/NF-kappaB-activated transcriptional program in the face of an overwhelming systemic infection suggests that variola gene products may ablate this response. These results provide a detailed picture of the host transcriptional response during smallpox infection, and may help guide the development of diagnostic, therapeutic, and prophylactic strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477590      PMCID: PMC523453          DOI: 10.1073/pnas.0405759101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria.

Authors:  Jennifer C Boldrick; Ash A Alizadeh; Maximilian Diehn; Sandrine Dudoit; Chih Long Liu; Christopher E Belcher; David Botstein; Louis M Staudt; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 2.  Diagnosis and management of smallpox.

Authors:  Joel G Breman; D A Henderson
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

Review 3.  Poxviruses and immune evasion.

Authors:  Bruce T Seet; J B Johnston; Craig R Brunetti; John W Barrett; Helen Everett; Cheryl Cameron; Joanna Sypula; Steven H Nazarian; Alexandra Lucas; Grant McFadden
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

4.  Large-scale analysis of the human and mouse transcriptomes.

Authors:  Andrew I Su; Michael P Cooke; Keith A Ching; Yaron Hakak; John R Walker; Tim Wiltshire; Anthony P Orth; Raquel G Vega; Lisa M Sapinoso; Aziz Moqrich; Ardem Patapoutian; Garret M Hampton; Peter G Schultz; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

5.  Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Authors:  Ariella M Rosengard; Yu Liu; Zhiping Nie; Robert Jimenez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 6.  Immune response to poxvirus infections in various animals.

Authors:  Scott A Smith; Girish J Kotwal
Journal:  Crit Rev Microbiol       Date:  2002       Impact factor: 7.624

7.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

Authors:  Thomas W Geisbert; Lisa E Hensley; Tom Larsen; Howard A Young; Douglas S Reed; Joan B Geisbert; Dana P Scott; Elliott Kagan; Peter B Jahrling; Kelly J Davis
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  A model for a smallpox-vaccination policy.

Authors:  Samuel A Bozzette; Rob Boer; Vibha Bhatnagar; Jennifer L Brower; Emmett B Keeler; Sally C Morton; Michael A Stoto
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

9.  Identification of genes periodically expressed in the human cell cycle and their expression in tumors.

Authors:  Michael L Whitfield; Gavin Sherlock; Alok J Saldanha; John I Murray; Catherine A Ball; Karen E Alexander; John C Matese; Charles M Perou; Myra M Hurt; Patrick O Brown; David Botstein
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

10.  The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation.

Authors:  Joanna L Shisler; Xiao-Lu Jin
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more
  53 in total

1.  Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman® low density immune arrays.

Authors:  Ann L Oberg; Neelam Dhiman; Diane E Grill; Jenna E Ryan; Richard B Kennedy; Gregory A Poland
Journal:  J Immunol Methods       Date:  2011-01-28       Impact factor: 2.303

2.  Smallpox: an ancient disease enters the modern era of virogenomics.

Authors:  Grant McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-12       Impact factor: 11.205

3.  Transcriptome signature in young children with acute otitis media due to Streptococcus pneumoniae.

Authors:  Keyi Liu; Linlin Chen; Ravinder Kaur; Michael Pichichero
Journal:  Microbes Infect       Date:  2012-01-23       Impact factor: 2.700

4.  Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death.

Authors:  Lisa M Sedger; Sarah R Osvath; Xiao-Ming Xu; Grace Li; Francis K-M Chan; John W Barrett; Grant McFadden
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection.

Authors:  Haitao Hu; Martin Nau; Phil Ehrenberg; Agnes-Laurence Chenine; Camila Macedo; Yu Zhou; Z John Daye; Zhi Wei; Maryanne Vahey; Nelson L Michael; Jerome H Kim; Mary Marovich; Silvia Ratto-Kim
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

6.  A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection.

Authors:  Marit Kramski; Kerstin Mätz-Rensing; Christiane Stahl-Hennig; Franz-Josef Kaup; Andreas Nitsche; Georg Pauli; Heinz Ellerbrok
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

Review 7.  Killing a killer: what next for smallpox?

Authors:  Grant McFadden
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

8.  Dissecting interferon-induced transcriptional programs in human peripheral blood cells.

Authors:  Simon J Waddell; Stephen J Popper; Kathleen H Rubins; Michael J Griffiths; Patrick O Brown; Michael Levin; David A Relman
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

9.  Analysis of vaccinia virus-host protein-protein interactions: validations of yeast two-hybrid screenings.

Authors:  Leiliang Zhang; Nancy Y Villa; Masmudur M Rahman; Sherin Smallwood; Donna Shattuck; Chris Neff; Max Dufford; Jerry S Lanchbury; Joshua Labaer; Grant McFadden
Journal:  J Proteome Res       Date:  2009-09       Impact factor: 4.466

10.  The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon.

Authors:  María del Mar Fernández de Marco; Alí Alejo; Paul Hudson; Inger K Damon; Antonio Alcami
Journal:  FASEB J       Date:  2009-12-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.